| 标题 |
Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medical Economics 作者:Jing Deng; Shuyan Gu; Hui Shao; Hengjin Dong; Dajin Zou; et al 出版日期:2015-08-20 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)